https://plus.google.com/117751271010052984954/posts/9MoC2B6PzZ3
8 hours ago - Need for Heightened Vigilance Illustrated by Pharmaceutical Manufacturer Mallinckrodt's Settlement with DEA for $35 Million Based on Suspicious Orders Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary Compounding Law; Health Care; Awareness of all Types of Compounding Issues; Pharmacy Benefit Managers (PBMs), Outsourcing Facilities Food and Drug Administration and Compliance Issues
Thursday, September 28, 2017
OIG says FDA needs to boost efficiency to meet federal law
Food Safety News-17 hours ago
It established the Office of Dietary Supplement Programs (ODSP) in 2015 after sales of dietary supplements grew to $40 billion a year, up from just $4 billion two ...
FDA improves access to reports of adverse drug reactions
FDA.gov-3 hours ago
In addition to the FAERS database for drugs and biologics, the agency has adverse event reporting programs and databases for foods, dietary supplements, and ...
European agencies highlight high levels and banned substances in ...
NutraIngredients.com-5 hours ago
European authorities have informed the EU of a number of dietary, food and sports supplements that contain either ingredients that exceed permitted levels or ...
Russian Court Orders Arrest of Doping Whistle-Blower Who Fled
New York Times-3 hours ago
Revelations by Grigory Rodchenkov, above, prompted investigations by the World Anti-Doping Agency and the International Olympic Committee into Russia ...
Russian Court Issues Arrest Warrant For Doping Whistle-Blower
RadioFreeEurope/RadioLiberty-11 hours ago
RadioFreeEurope/RadioLiberty-11 hours ago
Outsourcers Currently Compounding Six REMS-Protected Opioids
Inside Health Policy (subscription)-1 hour ago
At least six opioids that appear to be subject to Risk Evaluation and Mitigation Strategies with restricted distribution systems are currently being compounded b
Pharmaceutical Employee Admits Health Care Fraud Conspiracy Targeting State Health Benefits Programs-- Zappala recruited individuals in New Jersey to obtain very expensive and medically unnecessary compounded medications from an out-of-state pharmacy
Department of Justice
U.S. Attorney’s Office
District of New Jersey
FOR IMMEDIATE RELEASE
Thursday, September 28, 2017
Pharmaceutical Employee Admits Health Care Fraud Conspiracy Targeting State Health Benefits Programs
CAMDEN, N.J. – A Northfield, New Jersey, man today admitted defrauding New Jersey state health benefits programs and other insurers out of millions of dollars by submitting fraudulent claims for medically unnecessary prescriptions, Acting U.S. Attorney William E. Fitzpatrick and New Jersey Attorney General Christopher S. Porrino announced.
Richard Zappala, 45, a pharmaceutical sales representative, pleaded guilty before U.S. District Judge Robert B. Kugler in Camden federal court to an information charging him with conspiracy to commit health care fraud.
According to documents filed in this case and statements made in court:
From January 2015 through April 2016, Zappala recruited individuals in New Jersey to obtain very expensive and medically unnecessary compounded medications from an out-of-state pharmacy, identified in the informations as the “Compounding Pharmacy.” The conspirators learned that certain compound medication prescriptions – including pain, scar, antifungal, and libido creams, as well as vitamin combinations – were reimbursed for thousands of dollars for a one-month supply.
The conspirators also learned that some New Jersey state and local government and education employees, including teachers, firefighters, municipal police officers, and state troopers, had insurance coverage for these particular compound medications. An entity referred to in the informations as the “Pharmacy Benefits Administrator” provided pharmacy benefit management services for the State Health Benefits Program, which covers qualified state and local government employees, retirees, and eligible dependents, and the School Employees’ Health Benefits Program, which covers qualified local education employees, retirees, and eligible dependents. The Pharmacy Benefits Administrator would pay prescription drug claims and then bill the State of New Jersey for the amounts paid.
Zappala and conspirators working under him recruited public employees and other individuals covered by the Pharmacy Benefits Administrator to fraudulently obtain compounded medications from the Compounding Pharmacy without any evaluation by a medical professional that they were medically necessary. In return, the pharmacy paid one of Zappala’s conspirators a percentage of each prescription filled and paid by the Pharmacy Benefits Administrator, which was then distributed to Zappala and other members of the conspiracy.
Once he had recruited an employee covered by the Pharmacy Benefits Administrator, Zappala would obtain the employee’s insurance information and fill out a Compounding Pharmacy prescription form. He would select the compounded medications that paid the most without regard to their medical necessity.
Zappala would then get the prescriptions signed by doctors who never evaluated whether the patients had a medical necessity for the compounded medication. The prescriptions were then faxed to Compounding Pharmacy, which filled the prescriptions and billed the Pharmacy Benefits Administrator.
Zappala paid money and other benefits to doctors to reward them for signing prescriptions. He also paid recruiters under him and paid individuals with insurance coverage to reward them for agreeing to obtain prescriptions.
According to the information, the Pharmacy Benefits Administrator paid Compounding Pharmacy over $50 million for compounded medications mailed to individuals in New Jersey.
As part of his plea agreement, Zappala must forfeit $1,492,918.19 in criminal proceeds he received for his role in the scheme and pay restitution of at least $4,310,232.76.
Zappala faces a maximum penalty of 10 years in prison and a $250,000 fine, or twice the gross gain or loss from the offense. Sentencing is scheduled for Jan. 5, 2018.
Eight other conspirators – Matthew Tedesco, Robert Bessey, Michael Pepper, Thomas Hodnett, Steven Urbanski, John Gaffney, Judd Holt, and George Gavras – have pleaded guilty to their roles in the scheme and await sentencing.
Acting U.S. Attorney Fitzpatrick credited agents of the FBI’s Atlantic City Resident Agency, under the direction of Special Agent in Charge Timothy Gallagher in Newark, IRS – Criminal Investigation, under the direction of Special Agent in Charge Jonathan D. Larsen in Newark, and the U.S. Department of Labor, Office of Inspector General, under the direction of Special Agent in Charge Michael C. Mikulka in New York, with the investigation leading to the guilty plea. He also thanked the Division of Pensions and Financial Transactions in the State Attorney General’s Office, under the direction of Attorney General Porrino and Division Chief Eileen Schlindwein Den Bleyker, for its assistance in the investigation.
Defense counsel: Kevin E. Raphael Esq., Philadelphia, Pennsylvania
Attachment(s):
Component(s):
Press Release Number:
17-359
FDA Takes Important Steps to Stem the Tide of Opioid Misuse and Abuse
|
Subscribe to:
Posts (Atom)